Cellibre, Inc.
Biotechnology company · San Diego, California, United States
Cellibre, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2017. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $6.7 million sold in a notice filed in 2024.
Cellibre at a glance
What does Cellibre do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $2 million in total (2024). NIH funding came from the National Center for Complementary and Integrative Health.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $6.7 million sold (2024).
Frequently asked questions about Cellibre
Where is Cellibre headquartered?
Cellibre, Inc. is headquartered in San Diego, California, United States.
What does Cellibre do?
Cellibre, Inc. is a biotechnology company.
When was Cellibre founded?
The earliest incorporation on record for Cellibre, Inc. is in 2017, according to public company registers.
Similar companies
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences